Gastric Cancer Clinical Trials in Oklahoma City, Oklahoma

4 studies are recruiting for gastric cancer in Oklahoma City, Oklahoma right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    This is a Phase 1/2 open-label, multi-center, multi-national study with an initial dose escalation part to determine the recommended Phase II dose (RP2D) of MCLA-158 single agent in patients with mCRC. The dose escalation part has been completed and the RP2D will be further evaluated in an expansio…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    SSM OKC Hightower Clinical, Oklahoma City, Oklahoma
    Locations
    54 in total
    Run by
    Merus B.V.

    See if you can join NCT03526835 on ClinicalTrials.gov

  2. Combination of TATE and PD-1 Inhibitor in Liver Cancer

    This is a multi-center, open-label phase IIA study that investigates the preliminary efficacy of Trans-arterial Tirapazamine Embolization (TATE) treatment of liver cancer followed by a PD-1 checkpoint inhibitor (nivolumab). Patients with two types of cancers will be enrolled, advanced hepatocellula…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    University of Oklahoma Health Science Center, Oklahoma City, Oklahoma
    Locations
    3 in total
    Run by
    Teclison Ltd.

    See if you can join NCT03259867 on ClinicalTrials.gov

  3. A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

    A phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients with locally advanced or metastatic, relapsed or refractory carcinomas

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Dren Investigational Site, Oklahoma City, Oklahoma
    Locations
    10 in total
    Run by
    Dren Bio

    See if you can join NCT06999187 on ClinicalTrials.gov

  4. A Study of NX-1607 in Adults With Advanced Malignancies

    This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Oklahoma, Oklahoma City, Oklahoma
    Locations
    17 in total
    Run by
    Nurix Therapeutics, Inc.

    See if you can join NCT05107674 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.